Welcome to our dedicated page for Ionq SEC filings (Ticker: IONQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The IonQ, Inc. (NYSE: IONQ) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-powered summaries to help interpret complex documents. As a quantum platform company active in computing, networking, sensing, and security, IonQ uses its SEC filings to report on capital markets activity, acquisitions, governance changes, and executive compensation arrangements.
Investors can review Form 8-K filings where IonQ reports material events such as underwriting agreements for common stock, pre-funded warrants, and Series B warrants, as well as prospectus supplements covering resales of common stock by selling stockholders. Other 8-Ks describe unregistered sales of equity securities, registration rights agreements with institutions like Oxford Science Enterprises and Fortis Advisors, and the completion of acquisitions such as Oxford Ionics Limited and Vector Atomic, Inc.
Filings also detail board and executive changes. Recent 8-Ks and amendments outline the appointment of new directors, the transition of existing directors into advisory roles, and separation agreements for senior executives under IonQ’s Amended and Restated Executive Severance Plan. These documents specify cash severance, COBRA benefits, and equity vesting terms, providing insight into leadership transitions and compensation structures.
Through its registration statements and related supplements, IonQ discloses information about listed securities, including common stock and warrants trading on the New York Stock Exchange under the symbols IONQ and IONQ WS. AI-generated highlights on this page help users quickly identify key terms such as warrant exercise prices, expiration dates, and adjustment mechanisms, as well as the implications of registration rights and resale arrangements.
By using this filings page, readers can follow IonQ’s equity offerings, acquisition-related share issuances, insider and governance updates, and other regulatory disclosures, while AI summaries assist in understanding how each filing may relate to ownership, dilution, and the company’s strategic transactions.
IonQ, Inc. director reports option exercise and share sale under a pre-set trading plan. On 12/22/2025, the reporting person exercised a stock option for 5,000 shares of IonQ common stock at an exercise price of $4.61 per share. On the same date, 5,000 shares of common stock were sold at a price of $55 per share pursuant to a Rule 10b5-1 trading plan adopted on September 11, 2025.
After these transactions, the director beneficially owns 60,839 shares of IonQ common stock directly and holds 19,900 stock options (right to buy) following the partial exercise of an option originally covering 63,900 shares that vests in three equal annual installments beginning July 11, 2023.
IonQ security holder plans to sell 5,000 common shares under Rule 144. The shares are to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of $242,400.00, on the NYSE. The filing notes that there are 354,279,591 common shares outstanding, providing a baseline for the company’s total share count. The 5,000 shares were acquired on 12/22/2025 by exercising stock options for cash on the same date.
The notice also lists prior Rule 10b5-1 activity, showing that 10b5-1 sales for Kathryn Chou included 20,000 common shares sold on 12/11/2025 for gross proceeds of $1,027,980.00. By signing, the seller represents that they are not aware of undisclosed material adverse information about IonQ.
IonQ, Inc.'s President, CEO and director reported a sale of 16,290 shares of common stock on 12/11/2025 at a weighted average price of $50.4865 per share.
The shares were sold to satisfy the reporting person's tax liability arising from the vesting of restricted stock units. After this transaction, the insider directly beneficially owns 1,164,896 shares of IonQ common stock.
IonQ, Inc.'s Chief Business Officer reported selling 19,586 shares of common stock to satisfy tax obligations from vesting restricted stock units (RSUs). The shares were sold at a weighted average price of $50.4865, with transaction prices ranging from $49.09 to $52.00. Following this tax-related sale, the officer beneficially owns 216,457 shares of IonQ common stock directly.
IonQ, Inc. reported an insider share sale by a senior officer. The company’s CAO, CLO and Secretary disposed of 4,132 shares of common stock on 12/11/2025 at a weighted average price of $50.4865 in a transaction reported under code F.
The explanation states these shares were sold to satisfy the reporting person’s tax liability arising from the vesting of restricted stock units. Following this tax-related sale, the officer directly beneficially owns 110,322 shares of IonQ common stock.
IonQ, Inc. director reported an option exercise and share sale in the company’s stock. On 12/11/2025, the director exercised a stock option to acquire 20,000 shares of common stock at an exercise price of $4.61 per share. On the same day, the director sold 20,000 shares of common stock at a weighted average price of $51.399 per share under transaction code “S.” These trades were carried out pursuant to a Rule 10b5-1 trading plan adopted on September 11, 2025. Following the transactions, the director directly owned 60,839 shares of IonQ common stock and held 24,900 stock options, which are part of an option grant originally for 63,900 shares that vests in three equal annual installments starting July 11, 2023.
IonQ, Inc. (IONQ) Chief Financial and Operating Officer reported a routine share sale tied to equity compensation. On December 11, 2025, the officer disposed of 12,553 shares of common stock in a transaction coded "F," meaning the shares were sold to cover tax obligations from the vesting of restricted stock units (RSUs). The weighted average sale price was $50.4865 per share, with individual trades executed between $49.09 and $52.00. After this tax-related sale, the officer beneficially owned 428,201 shares of IonQ common stock. The filing also notes that a prior RSU award reported in an earlier filing was adjusted to vest over three years, with a portion having vested on December 10, 2025 and the remaining units vesting in equal quarterly installments, subject to continued service.
IonQ Inc. filed a notice of proposed insider stock sales under Rule 144. The filing covers the planned sale of 20,000 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $1,033,400. These shares were acquired on 12/11/2025 through the cash exercise of stock options granted by the issuer. The filing also notes that total common shares outstanding are 354,279,591, providing context for the size of the planned sale.
IonQ, Inc. insider plans additional share sale under Rule 144. A holder has filed a notice to sell 73,155 shares of IonQ common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of approximately $3,772,120.53. IonQ had 354,279,591 common shares outstanding. The shares to be sold were acquired on 12/11/2025 by exercising options under a registered plan and paid for in cash on the same date.
Over the past three months, the same seller and related joint accounts have already sold several IonQ common stock blocks, including 133,615 shares on 12/09/2025 for $7,181,124.81, 100,000 shares on 11/20/2025 for $4,686,054.00, and additional smaller sales. By signing the notice, the seller represents they are not aware of undisclosed material adverse information about IonQ’s operations.
IonQ, Inc. insider plans sale of common stock under Rule 144. A person associated with IonQ has filed a notice to sell 4,490 shares of common stock through E-TRADE Financial Corporation on the NYSE, with an approximate sale date of 12/11/2025 and an aggregate market value of 236,578. The filing notes that IonQ had 354,279,591 shares of common stock outstanding.
The 4,490 shares to be sold were acquired on 12/10/2025 through the vesting of restricted stock units as equity compensation from the issuer. The notice also discloses that the same seller, identified as Paul Dacier at IonQ’s address, sold 4,175 shares of common stock on 09/11/2025 for gross proceeds of 185,376.68. By signing, the seller represents they are not aware of undisclosed material adverse information about IonQ.
FAQ
What is the current stock price of Ionq (IONQ)?
What is the market cap of Ionq (IONQ)?
